NSI-189 is a novel neurogenic antidepressant in the nootropic category. Neurogenic drugs promote the development and growth of new neurons, or brain cells. This means that it could potentially repair damaged or missing brain cells that lead to a person being unable to experience happiness – or, in other words, who are depressed.
“The Novel Neurogenic Antidepressant”
- Reduce depressive symptoms
- Reduce anxiety
- Improve attention
- Improve memory
- Upregulates neurogenic factors in tandem with neurogenesis
- Promotes behavioral recovery in stroke
- Enhances cell proliferation and neurogenesis in stroke